Estrogen and estrogen receptor (ER) signaling have been found to have a protective role in HCC initiation and progression via the IL-6/STAT inflammatory pathways (Naugler et al., 2007; Yang et al., 2012). This evidence concerns the gene IL6 and hepatocellular carcinoma.